Neuropsychiatric symptoms of dementia and their management.
Authors:
I. Holmerová
Authors place of work:
Gerontologické centrum Praha
Published in the journal:
Geriatrie a Gerontologie 2018, 7, č. 3: 110-112
Category:
Review Article
Summary
Number of persons living with dementia is increasing with population ageing. Currently there are approximately 160 thousand persons living with dementia in the Czech Republic, most of them (cca 75%) living at home and cca 25% in institutions of either welfare or health care type. Care of persons with advanced dementia syndrome is demanding especially in situations when neuropsychiatric symptoms occur. Appropriate and skilled care, individualized attitude respecting needs and routines of persons with dementia, non-pharmacological interventions etc are the best way how to manage neuropsychiatric symptoms. However in some situation are these interventions not effective and it is necessary to consider medication. Antipsychotics are still frequently used in these situation despite the common knowledge of their serious side effects. Therefore it is necessary to consider pros and contras and alternative attitudes, state of syndrome progression, comorbidities, trigger factors (pain, dyscomfort) and alleviate them by non-pharmacological or pharmacological interventions. We suggest some principles of careful prescription of antipsychotics in practice, limitation of their use only for these cases in which patients benefit from their prescription.
Keywords:
dementia – Antipsychotics – neuropsychiatric symptoms of dementia – care coordination
Zdroje
1. Casey DA. Pharmacotherapy of Neuropsychiatric Symptoms of Dementia Pharmacotherapy and Dementia 2015;40(4): 284–287.
2. Watson-Wolfe K, Galik E, Klinedinst NJ. Application of the Antipsychotic Use in Dementia - Assessment Audit Tool to Facilitate Appropriate Antipsychotic Use in Long Term Care Residents with Dementia.
3. Chiu Y, Bero L, Hessol NA, et al. A Literature Review of Clinical Outcomes Associated with Antipsychotic Medication Use in North American Nursing Home Residents. Health policy.
4. Désaméricq G, Schürhoff F, Macquin-Mavier I, et al. Use of Antipsychotics: A Study from the French National Insurance Healthcare System Database. Pharmacology & Pharmacy 2015;06(08): 411–419.
5. Jennings L, Grossberg GT. Antipsychotics Continue to Have a Place in the Management of Difficult Behavior Problems in Patients With Dementia. Journal of the American Medical Directors Association 2013;14(6): 447–449.
6. Cipriani G, Danti S, Vedovello M, et al. Understanding delusion in dementia: A review. Geriatrics & gerontology international 2014;14(1): 32–39.
7. Blazer DG. Antipsychotics and Dementia: Where Do We Go From Here? Journal of the American Medical Directors Association 2013;14(4): 307–308.
8. Pollock BG, Mulsant BH. Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residents. CMAJ: Canadian Medical Association journal = journal de l‘Association medicale canadienne 2011;183(7): 778–779.
9. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD):long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8: 151–57; 2009(8): 151.7.
10. Banerjee S. The use of antipsychotic medication for people with dementiaTime for action. London: King´s College, 2009.
11. Morrison A. Antipsychotic prescribing in nursing homes: an audit report. Quality in Primary Care 2009;17: 359–62.
12. Shah SM, Carey IM, Harris T, et al. Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International journal of geriatric psychiatry 2011;26(4): 423–434.
13. Salzman C. Antipsychotics in Nursing Homes. Journal of Clinical Psychopharmacology. 2013;33(1):1-2.
14. Holmerova I, Rusina R, Jirák R. Rizika a nevýhody podávání antipsychotik v dlouhodobé péči u pacientů s demencí. Psychiatr praxi 2014; 15(1): 18–21.
15. VOP. Souhrnná zpráva o činnosti Veřejného ochránce práv 2013. Brno: Veřejný ochránce práv, 2014.
16. VOP. Ubytovací zařízení poskytující péči bez oprávnění. Brno: Veřejný ochránce práv Ombudsman, 2015.
17. Van der Putten MJ, Wetzels RB, et al. Antipsychotic drug prescription rates among Dutch nursing homes: the influence of patient characteristics and the dementia special care unit. Aging Ment Health. 2014;18(7): 828–32.
18. Sturdy D, Heath H, Ballard C, Burns A. Antipsychotic drugs in dementia: a best practice guide. Nursing standard. London: Department of Health; 2012.
19. HAS. Antipsychotics in person living with Alzheimer´s disease. Paris: Haute Autorité de Santé, 2012.
20. Morrison AP, Hutton P, Shiers D, Turkington D. Antipsychotics: is it time to introduce patient choice? The British journal of psychiatry: the journal of mental science. 2012;201: 83–84.
21. Whitaker R, Ballard C, Stafford J, et al. Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial. Trials 2013;14:13.
22. UK Got. Government response to Prof. S. Baneree´s report on the prescribing of antipsychotic drugs to people with dementia. London Government of the UK, 2009.
23. Schultze J, Bussche Hvd, Glaeske G, et al. Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances. European Neuropsychopharmacology 2013;23(9): 1034–42.
24. Galik E, Resnick B. Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents. Journal of psychiatric and mental health nursing. 2013;20(3): 244–52.
25. Simoni-Wastila L, Wei YJ, Luong M, et al. Quality of psychopharmacological medication use in nursing home residents. Research in social & administrative pharmacy : RSAP. 2014;10(3): 494–507.
Štítky
Geriatrics General practitioner for adults Orthopaedic prostheticsČlánok vyšiel v časopise
Geriatrics and Gerontology
2018 Číslo 3
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- The irreplaceable role of rehabilitation in geriatric patients at post-acute care centres.
- Needs of senior patients in hospital care – analysis of Czech literature review results.
- Neuropsychiatric symptoms of dementia and their management.
- Care integration – coordination barriers – aspects of integrated care – patients with complex needs – Czech Republic